STRATA Skin Sciences, Inc. (SSKN)
USD 2.59
(-1.19%)
USD 2.59
(-1.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 7.51 Million USD | 149.92% |
| 2022 | 3 Million USD | 165.99% |
| 2021 | -4.55 Million USD | -1739.21% |
| 2020 | 278 Thousand USD | -48.23% |
| 2019 | 537 Thousand USD | 105.91% |
| 2018 | -9.09 Million USD | -239.25% |
| 2017 | 6.52 Million USD | -67.2% |
| 2016 | 19.9 Million USD | 10.71% |
| 2015 | 17.97 Million USD | 379.48% |
| 2014 | -6.43 Million USD | -70.05% |
| 2013 | -3.78 Million USD | 51.88% |
| 2012 | -7.86 Million USD | 71.92% |
| 2011 | -27.99 Million USD | 8.27% |
| 2010 | -30.52 Million USD | -2.86% |
| 2009 | -29.67 Million USD | -96.9% |
| 2008 | -15.06 Million USD | 21.5% |
| 2007 | -19.19 Million USD | 8.32% |
| 2006 | -20.93 Million USD | -13.16% |
| 2005 | -18.5 Million USD | -16923.16% |
| 2004 | -108.7 Thousand USD | -81.18% |
| 2003 | -60 Thousand USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 9.69 Million USD | 10.6% |
| 2024 Q1 | 9.97 Million USD | 32.67% |
| 2023 FY | 7.51 Million USD | 149.92% |
| 2023 Q1 | 5.56 Million USD | 84.97% |
| 2023 Q3 | 8.57 Million USD | 27.32% |
| 2023 Q2 | 6.73 Million USD | 21.04% |
| 2023 Q4 | 7.51 Million USD | -12.32% |
| 2022 Q4 | 3 Million USD | 233.74% |
| 2022 Q3 | 901 Thousand USD | 142.34% |
| 2022 FY | 3 Million USD | 165.99% |
| 2022 Q1 | -2.95 Million USD | 35.18% |
| 2022 Q2 | -2.12 Million USD | 27.96% |
| 2021 Q4 | -4.55 Million USD | 8.14% |
| 2021 Q1 | 748 Thousand USD | 169.06% |
| 2021 Q2 | -905 Thousand USD | -220.99% |
| 2021 Q3 | -4.96 Million USD | -448.18% |
| 2021 FY | -4.55 Million USD | -1739.21% |
| 2020 Q4 | 278 Thousand USD | 392.63% |
| 2020 Q3 | -95 Thousand USD | 46.93% |
| 2020 Q2 | -179 Thousand USD | -139.25% |
| 2020 Q1 | 456 Thousand USD | -15.08% |
| 2020 FY | 278 Thousand USD | -48.23% |
| 2019 Q1 | -8.18 Million USD | 9.94% |
| 2019 Q3 | -7.31 Million USD | -4.91% |
| 2019 Q4 | 537 Thousand USD | 107.35% |
| 2019 FY | 537 Thousand USD | 105.91% |
| 2019 Q2 | -6.96 Million USD | 14.87% |
| 2018 Q2 | -7.07 Million USD | -199.42% |
| 2018 Q1 | 7.11 Million USD | 8.98% |
| 2018 Q4 | -9.09 Million USD | -6.62% |
| 2018 FY | -9.09 Million USD | -239.25% |
| 2018 Q3 | -8.52 Million USD | -20.54% |
| 2017 FY | 6.52 Million USD | -67.2% |
| 2017 Q1 | 20.69 Million USD | 3.94% |
| 2017 Q2 | 21.16 Million USD | 2.29% |
| 2017 Q3 | 7.68 Million USD | -63.69% |
| 2017 Q4 | 6.52 Million USD | -15.06% |
| 2016 FY | 19.9 Million USD | 10.71% |
| 2016 Q4 | 19.9 Million USD | 0.29% |
| 2016 Q3 | 19.84 Million USD | 2.19% |
| 2016 Q2 | 19.42 Million USD | 3.71% |
| 2016 Q1 | 18.72 Million USD | 4.16% |
| 2015 Q4 | 17.97 Million USD | 5.2% |
| 2015 Q3 | 17.09 Million USD | 41.27% |
| 2015 Q2 | 12.09 Million USD | 443.14% |
| 2015 Q1 | -3.52 Million USD | 45.19% |
| 2015 FY | 17.97 Million USD | 379.48% |
| 2014 Q2 | -4.2 Million USD | 48.27% |
| 2014 Q4 | -6.43 Million USD | 31.81% |
| 2014 Q3 | -9.43 Million USD | -124.49% |
| 2014 FY | -6.43 Million USD | -70.05% |
| 2014 Q1 | -8.12 Million USD | -114.72% |
| 2013 Q2 | -9.79 Million USD | 40.16% |
| 2013 FY | -3.78 Million USD | 51.88% |
| 2013 Q4 | -3.78 Million USD | -44.37% |
| 2013 Q3 | -2.62 Million USD | 73.24% |
| 2013 Q1 | -16.36 Million USD | -108.11% |
| 2012 Q4 | -7.86 Million USD | 40.78% |
| 2012 Q2 | -17.21 Million USD | 22.82% |
| 2012 FY | -7.86 Million USD | 71.92% |
| 2012 Q3 | -13.27 Million USD | 22.86% |
| 2012 Q1 | -22.3 Million USD | 20.34% |
| 2011 Q2 | -20.94 Million USD | 19.58% |
| 2011 Q4 | -27.99 Million USD | -64.69% |
| 2011 Q3 | -16.99 Million USD | 18.83% |
| 2011 FY | -27.99 Million USD | 8.27% |
| 2011 Q1 | -26.04 Million USD | 14.68% |
| 2010 Q4 | -30.52 Million USD | 14.64% |
| 2010 FY | -30.52 Million USD | -2.86% |
| 2010 Q3 | -35.75 Million USD | -41.25% |
| 2010 Q2 | -25.31 Million USD | 15.74% |
| 2010 Q1 | -30.04 Million USD | -1.24% |
| 2009 Q3 | -24.77 Million USD | -219.86% |
| 2009 FY | -29.67 Million USD | -96.9% |
| 2009 Q4 | -29.67 Million USD | -19.75% |
| 2009 Q1 | -11.25 Million USD | 25.32% |
| 2009 Q2 | -7.74 Million USD | 31.16% |
| 2008 Q3 | -18.77 Million USD | -59.62% |
| 2008 Q2 | -11.76 Million USD | 26.02% |
| 2008 Q1 | -15.9 Million USD | 17.17% |
| 2008 FY | -15.06 Million USD | 21.5% |
| 2008 Q4 | -15.06 Million USD | 19.74% |
| 2007 Q4 | -19.19 Million USD | 17.51% |
| 2007 Q2 | -15.07 Million USD | 16.97% |
| 2007 Q1 | -18.15 Million USD | 13.29% |
| 2007 Q3 | -23.27 Million USD | -54.37% |
| 2007 FY | -19.19 Million USD | 8.32% |
| 2006 FY | -20.93 Million USD | -13.16% |
| 2006 Q4 | -20.93 Million USD | -118.15% |
| 2006 Q3 | -9.59 Million USD | -46.85% |
| 2006 Q2 | -6.53 Million USD | 18.23% |
| 2006 Q1 | -7.99 Million USD | 56.8% |
| 2005 FY | -18.5 Million USD | -16923.16% |
| 2005 Q3 | -1.34 Million USD | -663.74% |
| 2005 Q4 | -18.5 Million USD | -1275.05% |
| 2005 Q2 | -176.2 Thousand USD | 0.0% |
| 2004 FY | -108.7 Thousand USD | -81.18% |
| 2004 Q4 | -108.7 Thousand USD | 0.0% |
| 2003 FY | -60 Thousand USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 72.251% |
| BrainsWay Ltd. | -10.32 Million USD | 172.82% |
| Cerus Corporation | 84.35 Million USD | 91.091% |
| Envoy Medical, Inc. | -3.81 Million USD | 297.037% |
| electroCore, Inc. | -9.95 Million USD | 175.49% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 246.634% |
| IceCure Medical Ltd | -9.93 Million USD | 175.649% |
| Inogen, Inc. | -103.56 Million USD | 107.256% |
| OrthoPediatrics Corp. | -9.26 Million USD | 181.094% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 306.399% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 157.379% |
| MaxCyte, Inc. | -27.76 Million USD | 127.068% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 246.26% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1405.215% |
| Orthofix Medical Inc. | 96.44 Million USD | 92.208% |
| PAVmed Inc | 29.08 Million USD | 74.163% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 144.365% |
| RxSight, Inc. | -6.68 Million USD | 212.5% |
| Sight Sciences, Inc. | -102.71 Million USD | 107.316% |
| SI-BONE, Inc. | 5.72 Million USD | -31.358% |
| TELA Bio, Inc. | -3.94 Million USD | 290.301% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 86.89% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -2034.943% |
| Acutus Medical, Inc. | 12.27 Million USD | 38.798% |
| Talis Biomedical Corporation | -57.06 Million USD | 113.169% |
| Spectral AI, Inc. | -3.5 Million USD | 314.653% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 115.647% |
| CVRx, Inc. | -59.95 Million USD | 112.534% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -278.753% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -488.195% |
| Bioventus Inc. | 372.51 Million USD | 97.983% |
| Venus Concept Inc. | 74.3 Million USD | 89.886% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 173.807% |
| LivaNova PLC | 62.53 Million USD | 87.982% |
| 908 Devices Inc. | -115.09 Million USD | 106.529% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 97.657% |
| Nemaura Medical Inc. | 9.92 Million USD | 24.282% |
| NeuroPace, Inc. | 54.33 Million USD | 86.17% |
| LENSAR, Inc. | -18.31 Million USD | 141.039% |
| Apyx Medical Corporation | -5.15 Million USD | 245.894% |
| Cutera, Inc. | 288.3 Million USD | 97.393% |
| BioSig Technologies, Inc. | 262 Thousand USD | -2768.321% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 117.146% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 181.694% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.465% |
| Axonics, Inc. | -77.19 Million USD | 109.735% |
| Outset Medical, Inc. | 67.67 Million USD | 88.896% |
| IRIDEX Corporation | -4.28 Million USD | 275.257% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 104.221% |
| IRadimed Corporation | -47.71 Million USD | 115.748% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 348.348% |
| INVO Bioscience, Inc. | 8.45 Million USD | 11.077% |
| Telesis Bio, Inc. | 32.63 Million USD | 76.973% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 400.344% |
| Varex Imaging Corporation | 316.9 Million USD | 97.629% |
| Quipt Home Medical Corp. | 81.73 Million USD | 90.806% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 370.129% |
| Pulmonx Corporation | -42.36 Million USD | 117.741% |
| Dynatronics Corporation | 6.2 Million USD | -21.131% |
| Modular Medical, Inc. | -8.04 Million USD | 193.447% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 274.889% |
| Semler Scientific, Inc. | -57.13 Million USD | 113.154% |
| InMode Ltd. | -135.39 Million USD | 105.55% |
| Bruker Corporation | 891.3 Million USD | 99.157% |
| Cytosorbents Corporation | 4.18 Million USD | -79.698% |
| DexCom, Inc. | 2.02 Billion USD | 99.629% |
| Align Technology, Inc. | -840.47 Million USD | 100.894% |
| Viveve Medical, Inc. | -13.81 Million USD | 154.405% |
| ZimVie Inc. | 450.41 Million USD | 98.332% |
| Movano Inc. | -5.86 Million USD | 228.111% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 105.589% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1405.215% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -278.753% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 97.894% |
| Profound Medical Corp. | -18.17 Million USD | 141.34% |
| Insulet Corporation | 798.1 Million USD | 99.058% |
| enVVeno Medical Corporation | -2.21 Million USD | 438.819% |
| Surmodics, Inc. | -12.01 Million USD | 162.552% |
| iCAD, Inc. | -21.2 Million USD | 135.433% |
| Nuwellis, Inc. | -2.81 Million USD | 366.584% |
| Biotricity, Inc. | 23.09 Million USD | 67.457% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 91.976% |
| Aethlon Medical, Inc. | -4.5 Million USD | 266.938% |
| InspireMD, Inc. | -8.04 Million USD | 193.412% |
| PAVmed Inc. | 29.08 Million USD | 74.163% |
| BIOLASE, Inc. | 11.34 Million USD | 33.754% |
| Beyond Air, Inc. | 6.22 Million USD | -20.645% |
| FONAR Corporation | -14.66 Million USD | 151.243% |
| AxoGen, Inc. | 32.26 Million USD | 76.709% |
| Vivani Medical, Inc. | 42 Thousand USD | -17792.857% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 170.51% |
| Inari Medical, Inc. | -7.16 Million USD | 204.943% |
| UFP Technologies, Inc. | 40.77 Million USD | 81.569% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -144.898% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 257.504% |
| Tenon Medical, Inc. | -1.25 Million USD | 698.805% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 198.804% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 163.012% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.661% |
| Sintx Technologies, Inc. | 905 Thousand USD | -730.387% |
| NanoVibronix, Inc. | -3.27 Million USD | 329.256% |
| Quanterix Corporation | -132.95 Million USD | 105.652% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 370.129% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 133.602% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.003% |
| TransMedics Group, Inc. | 121.13 Million USD | 93.796% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 128.705% |
| NeuroMetrix, Inc. | -1.49 Million USD | 604.0% |
| Hyperfine, Inc. | -75.61 Million USD | 109.938% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 95.062% |
| Biomerica, Inc. | -3.38 Million USD | 322.009% |
| Bone Biologics Corporation | -3.02 Million USD | 348.301% |
| AVITA Medical, Inc. | -26.23 Million USD | 128.649% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 508.777% |
| Silk Road Medical, Inc | 64.42 Million USD | 88.335% |